According to prospective cohort studies conducted on the levels of PSA and development of prostate cancer among patients without a disorder of the prostate gland, the higher the baseline PSA levels, the more likely the patients would have a high risk of prostate cancer [24,25]. This evidence concerns the gene KLK3 and Familial prostate cancer.